191 related articles for article (PubMed ID: 15530258)
1. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.
Martel CL; Li Y; Beckett L; Chew H; Christensen S; Davies A; Lam KS; Lau DH; Meyers FJ; O'donnell RT; Richman C; Scudder S; Tanaka M; Tuscano J; Welborn J; Wun T; Gandara DR; Lara PN
Cancer J; 2004; 10(5):294-300. PubMed ID: 15530258
[TBL] [Abstract][Full Text] [Related]
2. Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign.
Umutyan A; Chiechi C; Beckett LA; Paterniti DA; Turrell C; Gandara DR; Davis SW; Wun T; Chen MS; Lara PN
Cancer; 2008 Jan; 112(1):212-9. PubMed ID: 18008353
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
Lara PN; Paterniti DA; Chiechi C; Turrell C; Morain C; Horan N; Montell L; Gonzalez J; Davis S; Umutyan A; Martel CL; Gandara DR; Wun T; Beckett LA; Chen MS
J Clin Oncol; 2005 Dec; 23(36):9282-9. PubMed ID: 16361626
[TBL] [Abstract][Full Text] [Related]
5. Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate.
Mackay CB; Antonelli KR; Bruinooge SS; Saint Onge JM; Ellis SD
Cancer; 2017 Aug; 123(15):2893-2900. PubMed ID: 28334438
[TBL] [Abstract][Full Text] [Related]
6. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
[TBL] [Abstract][Full Text] [Related]
7. Effect of state-mandated insurance coverage on accrual to community cancer clinical trials.
Ellis SD; Carpenter WR; Minasian LM; Weiner BJ
Contemp Clin Trials; 2012 Sep; 33(5):933-41. PubMed ID: 22683991
[TBL] [Abstract][Full Text] [Related]
8. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.
Sateren WB; Trimble EL; Abrams J; Brawley O; Breen N; Ford L; McCabe M; Kaplan R; Smith M; Ungerleider R; Christian MC
J Clin Oncol; 2002 Apr; 20(8):2109-17. PubMed ID: 11956272
[TBL] [Abstract][Full Text] [Related]
9. Clinical trial accrual among new cancer patients at a community-based cancer center.
Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
[TBL] [Abstract][Full Text] [Related]
10. Support the "Access to Cancer Clinical Trials Act" to ensure coverage of routine patient-care costs.
Halpern IM; Waters B
ONS News; 2002 Sep; 17(9):6. PubMed ID: 12244867
[No Abstract] [Full Text] [Related]
11. Evidence-based approaches to overcoming barriers to clinical trial accrual.
Edelman MJ
Cancer J; 2004; 10(5):288-9. PubMed ID: 15530255
[No Abstract] [Full Text] [Related]
12. Cost considerations as potential barriers to cancer treatment.
Guidry JJ; Aday LA; Zhang D; Winn RJ
Cancer Pract; 1998; 6(3):182-7. PubMed ID: 9652250
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial recruitment in rural South Carolina: a comparison of investigators' perceptions and potential participant eligibility.
Bergeron CD; Foster C; Friedman DB; Tanner A; Kim SH
Rural Remote Health; 2013; 13(4):2567. PubMed ID: 24325179
[TBL] [Abstract][Full Text] [Related]
14. Reimbursement Matters: Overcoming Barriers to Clinical Trial Accrual.
Lee SJC; Murphy CC; Gerber DE; Geiger AM; Halm E; Nair RG; Cox JV; Tiro JA; Skinner CS
Med Care; 2021 May; 59(5):461-466. PubMed ID: 33492049
[TBL] [Abstract][Full Text] [Related]
15. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.
Logan JK; Tang C; Liao Z; Lee JJ; Heymach JV; Swisher SG; Welsh JW; Zhang J; Lin SH; Gomez DR
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):770-777. PubMed ID: 28244413
[TBL] [Abstract][Full Text] [Related]
17. Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.
Nipp RD; Lee H; Powell E; Birrer NE; Poles E; Finkelstein D; Winkfield K; Percac-Lima S; Chabner B; Moy B
Oncologist; 2016 Apr; 21(4):467-74. PubMed ID: 26975867
[TBL] [Abstract][Full Text] [Related]
18. Mandatory health insurance coverage for cancer clinical trials.
Murphy LC
McGeorge Law Rev; 2001-2002; 33():314-22. PubMed ID: 15871150
[No Abstract] [Full Text] [Related]
19. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
[TBL] [Abstract][Full Text] [Related]
20. Barriers to participation in clinical trials: a physician survey.
Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
